Document Detail

The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
MedLine Citation:
PMID:  18823890     Owner:  NLM     Status:  MEDLINE    
Increased oxidative stress (SOX), inflammation and prevalence of cardiovascular disease (CVD) have been reported in end-stage renal disease (ESRD), but their associations with kynurenine (KYN) pathway activation remain unknown. We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls. Analysis of TRP degradation through the KYN pathway demonstrated that in uremia the concentrations of this aminoacid were decreased by 40-60% in comparison with controls. In contrast, the plasma levels of KYN and 3-HKYN in ESRD patients were increased by 32-96% and 184-306%, respectively. These changes were accompanied by significant increase in the kyn/trp ratios by 140-240%, and 3-hkyn/kyn ratios by 40-154% in uremics compared to controls. ESRD patients showed a significant increase in Cu/Zn SOD, total peroxide and hs CRP levels between controls and all patients group. KYN and 3-HKYN were positively associated with inflammation and SOX markers in uremics. Logistic regression analysis showed that age, gender, presence of DM (all p<0.001), elevated hs CRP (p<0.01) and 3-HKYN levels (p<0.05) were independently associated with the presence of CVD in this population. These results suggest a relationship between KYN pathway activation and increased SOX, inflammation and CVD prevalence in ESRD patients.
Krystyna Pawlak; Tomasz Domaniewski; Michal Mysliwiec; Dariusz Pawlak
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-08-26
Journal Detail:
Title:  Atherosclerosis     Volume:  204     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-04     Completed Date:  2009-08-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  309-14     Citation Subset:  IM    
Department of Monitored Pharmacotherapy, Medical University, Bialystok, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Biological Markers / blood
C-Reactive Protein / analysis
Cardiovascular Diseases / blood,  epidemiology,  etiology*
Case-Control Studies
Cross-Sectional Studies
Diabetes Complications / blood,  etiology
Inflammation / blood,  epidemiology,  etiology*
Kidney Failure, Chronic / blood*,  complications,  epidemiology
Kynurenine / analogs & derivatives*,  blood
Logistic Models
Middle Aged
Oxidative Stress*
Peroxides / blood
Risk Assessment
Risk Factors
Sex Factors
Superoxide Dismutase / blood
Tryptophan / blood*
Reg. No./Substance:
0/Biological Markers; 0/Peroxides; 343-65-7/Kynurenine; 484-78-6/3-hydroxykynurenine; 73-22-3/Tryptophan; 9007-41-4/C-Reactive Protein; EC Dismutase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable c...
Next Document:  Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-...